|
Re: MOA of Apabetalone - only affects sick patients
|
5
|
Resverlogix Corp.
|
Apr 15, 2019 08:31AM
|
|
Re: Apabetalone publication in "Current Opinion in Nephrology & Hypertension"
|
5
|
Resverlogix Corp.
|
Jan 30, 2020 10:17AM
|
|
March Madness
|
5
|
Resverlogix Corp.
|
Mar 14, 2017 03:35PM
|
|
Re: Question on Rosuvastatin versus Astorvastatin
|
5
|
Resverlogix Corp.
|
Sep 06, 2019 09:25AM
|
|
Re: Update
|
5
|
Resverlogix Corp.
|
Feb 13, 2018 08:54PM
|
|
Re: Pfizer /Astellas perfect affair ...
|
5
|
Resverlogix Corp.
|
Aug 23, 2016 03:10PM
|
|
Re: Link for tomorrow morning late breaker results
|
5
|
Resverlogix Corp.
|
Nov 15, 2019 03:47PM
|
|
NYC events
|
5
|
Resverlogix Corp.
|
Aug 31, 2018 03:21PM
|
|
Managing CKD, Diabetes & CVD: Is epigenetics a new way forward?
|
5
|
Resverlogix Corp.
|
May 17, 2017 11:55AM
|
|
Re: Friedreich’s Ataxia Therapy News - Very interesting
|
5
|
Resverlogix Corp.
|
May 26, 2017 02:27PM
|
|
Re: One thought I can't completely let go....
|
5
|
Resverlogix Corp.
|
Feb 15, 2019 10:43AM
|
|
Re: BETonMACE top line data
|
5
|
Resverlogix Corp.
|
Jan 16, 2018 08:39PM
|
|
Re: The last DSMB update of Feb 26th....
|
5
|
Resverlogix Corp.
|
Jun 25, 2018 02:45PM
|
|
Re: 8 Minutes at AHA
|
5
|
Resverlogix Corp.
|
Oct 25, 2019 05:00PM
|
|
Re: Resverlogix tweet regarding apabetalone/CKD
|
5
|
Resverlogix Corp.
|
May 17, 2017 11:57AM
|
|
Kidney Trial
|
5
|
Resverlogix Corp.
|
Jul 11, 2018 01:54PM
|
|
Why Resverlogix is important to Zenith, and vice versa?
|
5
|
Zenith Epigenetics
|
Dec 06, 2015 09:21PM
|
|
Resverlogix Secures One-Year Extension of Maturity Date of Debenture
|
5
|
Resverlogix Corp.
|
Jul 22, 2020 09:03AM
|
|
Re: BET inhibitor and BRD4 papers keep piling up
|
5
|
Resverlogix Corp.
|
Sep 25, 2017 10:19PM
|
|
Re: ZEN-3694 mCRPC Trial Status
|
5
|
Zenith Epigenetics
|
Oct 25, 2017 04:05PM
|
